Lannebo Fonder’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.08M Hold
28,000
0.14% 27
2023
Q3
$1.28M Hold
28,000
0.19% 27
2023
Q2
$2.07M Hold
28,000
0.29% 28
2023
Q1
$1.64M Hold
28,000
0.26% 29
2022
Q4
$1.41M Buy
28,000
+4,000
+17% +$240K 0.27% 30
2022
Q3
$2.09M Buy
24,000
+1,000
+4% +$105K 0.42% 30
2022
Q2
$2.62M Buy
23,000
+3,000
+15% +$344K 0.48% 27
2022
Q1
$2.59M Hold
20,000
0.36% 32
2021
Q4
$3.61M Sell
20,000
-5,555
-22% -$964K 0.43% 29
2021
Q3
$3.79M Hold
25,555
0.47% 30
2021
Q2
$3.87M Buy
25,555
+1,555
+6% +$216K 0.48% 30
2021
Q1
$3.12M Sell
24,000
-500
-2% -$64.1K 0.42% 31
2020
Q4
$2.94M Sell
24,500
-4,000
-14% -$392K 0.39% 32
2020
Q3
$2.13M Buy
28,500
+11,412
+67% +$791K 0.3% 32
2020
Q2
$1.21M Buy
17,088
+5,688
+50% +$389K 0.21% 34
2020
Q1
$748K Buy
11,400
+5,700
+100% +$454K 0.21% 31
2019
Q4
$466K Buy
+5,700
New +$437K 0.12% 29

Other funds holding OMCL

Lannebo Fonder's OMCL Position: Q4 2023 in Review

Lannebo Fonder held its Omnicell (OMCL) position steady in Q4 2023 at 28,000 shares worth $1.08M. The position accounts for 0.14% of the portfolio, ranked #27.

Lannebo Fonder first reported a position in OMCL in Q4 2019 and has held it in 17 quarters since. The position peaked at $3.87M in Q2 2021. 290 funds tracked by Wall St. Rank hold OMCL as of Q4 2023.

  • Lannebo Fonder held 28,000 shares of Omnicell worth $1.08M as of Q4 2023.
  • Lannebo Fonder left its Omnicell share count unchanged in Q4 2023.
  • Omnicell made up 0.14% of Lannebo Fonder's portfolio in Q4 2023, its #27 holding.
  • Lannebo Fonder first reported a position in Omnicell in Q4 2019 and has held it in 17 quarters since.
  • Lannebo Fonder's Omnicell position peaked at $3.87M in Q2 2021.
  • 290 funds tracked by Wall St. Rank held Omnicell as of Q4 2023.

Based on Lannebo Fonder's 13F filing for Q4 2023, filed 24 Jan 2024.